International Journal of Alzheimer’s Disease

Copper Status in Alzheimer's Disease and other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies


Publishing date
01 Nov 2011
Status
Published
Submission deadline
01 May 2011

Lead Editor

1Department of Neuroscience, AFaR, Ospedale Fatebenefratelli, Isola Tiberina, Rome, Italy

2Department of Neurology, University Hospital Utrecht, Utrecht, The Netherlands

3Roberts Laboratory for Neurodegenerative Disease Research, Sun Health Research Institute, Sun City, AZ, USA

4Departments of Human Genetics and Internal Medicine, University of Michigan Medical School, 5022 Kresge Building II, Ann Arbor, MI, USA


Copper Status in Alzheimer's Disease and other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies

Description

Alzheimer's disease (AD) is a leading cause of death worldwide. It is a genetically heterogeneous syndrome which includes a broad spectrum of phenotypes. Recent advances in biology and medicine have introduced metals, particularly copper, as influencing agents in AD, thus improving understanding of the mechanisms and electrophysiology underlying the pathology. Increasing information has led to the development of new models or tools to characterize defective pathways of copper trafficking linked to neurodegenerative processes and the rational for phase II and III clinical trials as well.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the molecular pathology underlying copper involvement in AD. Potential topics include, but are not limited to:

  • Advances in metal toxicity as well as genetics of AD
  • Latest technologies or strategies to point out metallobiological processes subtending typical deficits of AD
  • Role of inflammation related to copper status in AD
  • Metal-proteins interplay in AD, in mild cognitive impairment, and in other copper diseases of neurodegeneration other than AD
  • Recent advances in drug strategy based on metallobiology of AD as well as biological molecules which induce or maintain a state of copper malabsorption
  • The increased toxicity of oral ingestion of inorganic copper (such as in drinking water or copper supplements) relative to organically bound copper in food
  • The interaction of lipids, for example, from a high fat diet, and copper in producing neurotoxicity
  • The mechanisms whereby aging increases susceptibility to copper toxicity in the brain

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

International Journal of Alzheimer’s Disease
 Journal metrics
See full report
Acceptance rate11%
Submission to final decision95 days
Acceptance to publication26 days
CiteScore8.800
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.